These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 9437218)

  • 1. Multiple endocrine neoplasia type 2: recent progress in diagnosis and management.
    Heshmati HM; Hofbauer LC
    Eur J Endocrinol; 1997 Dec; 137(6):572-8. PubMed ID: 9437218
    [No Abstract]   [Full Text] [Related]  

  • 2. [Management of multiple endocrine neoplasia syndrome type 2 families in association with rare germline mutations of the RET proto-oncogene].
    Fitze G; Saeger HD; Roesner D; Schackert HK
    Klin Padiatr; 2004; 216(5):270-6. PubMed ID: 15455293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis of multiple endocrine neoplasia [MEN] 2A, 2B and familial medullary thyroid cancer [FMTC] by multiplex PCR and heteroduplex analyses of RET proto-oncogene mutations.
    Kambouris M; Jackson CE; Feldman GL
    Hum Mutat; 1996; 8(1):64-70. PubMed ID: 8807338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Early diagnosis of multiple endocrine neoplasia type 2 (MEN 2) by detection of mutated RET proto-oncogene carriers].
    Sansó G; Domené HM; Iorcansky S; Barontini M
    Medicina (B Aires); 1998; 58(2):179-84. PubMed ID: 9706252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic basis of endocrine disease: multiple endocrine neoplasia type 2.
    Mulligan LM; Ponder BA
    J Clin Endocrinol Metab; 1995 Jul; 80(7):1989-95. PubMed ID: 7608246
    [No Abstract]   [Full Text] [Related]  

  • 6. Very early detection of RET proto-oncogene mutation is crucial for preventive thyroidectomy in multiple endocrine neoplasia type 2 children: presence of C-cell malignant disease in asymptomatic carriers.
    Sanso GE; Domene HM; Garcia R; Pusiol E; de M; Roque M; Ring A; Perinetti H; Elsner B; Iorcansky S; Barontini M
    Cancer; 2002 Jan; 94(2):323-30. PubMed ID: 11900218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [One gene--four diseases: on the importance of mutations in the ret gene in MEN 2A, MEN 2B, Hirschsprung disease and medullary thyroid carcinoma].
    Fehmann HC; Göke B
    Z Gastroenterol; 1994 Jul; 32(7):416-7. PubMed ID: 7975780
    [No Abstract]   [Full Text] [Related]  

  • 8. [Diagnosis and therapy of medullary thyroid carcinoma].
    Obara T; Kanbe M; Iihara M; Yamaguchi K; Futami H
    Nihon Naika Gakkai Zasshi; 1997 Jul; 86(7):1202-8. PubMed ID: 9379100
    [No Abstract]   [Full Text] [Related]  

  • 9. [Multiple endocrine neoplasia type 2a and 2b].
    Vestergaard P
    Ugeskr Laeger; 1996 Jan; 158(5):590-3. PubMed ID: 8607216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [From gene to disease; from the RET gene to multiple endocrine neoplasia types 2A and 2B, sporadic and familial medullary thyroid carcinoma, Hirschsprung disease and papillary thyroid carcinoma].
    Hofstra RM; van der Luijt RB; Lips CJ
    Ned Tijdschr Geneeskd; 2001 Nov; 145(46):2217-21. PubMed ID: 11757244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Molecular diagnosis of multiple type 2 endocrine neoplasia].
    Amosenko FA; Pushkash K; Frilling A; Kozlova VN; Liubchenko LN; Kazubskaia TP; Brelysh KE; Gar'kavtseva RF; Kalinin VN
    Vestn Ross Akad Med Nauk; 2001; (2):34-7. PubMed ID: 11338505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unresolved issues in the genesis and management of multiple endocrine neoplasia type 2.
    Gagel RF
    Horm Metab Res; 1997 Mar; 29(3):135-7. PubMed ID: 9137984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple endocrine neoplasia type 2.
    Forster-Gibson CJ; Mulligan LM
    Eur J Cancer; 1994; 30A(13):1969-74. PubMed ID: 7734209
    [No Abstract]   [Full Text] [Related]  

  • 14. RET activation by germline MEN2A and MEN2B mutations.
    Borrello MG; Smith DP; Pasini B; Bongarzone I; Greco A; Lorenzo MJ; Arighi E; Miranda C; Eng C; Alberti L
    Oncogene; 1995 Dec; 11(11):2419-27. PubMed ID: 8570194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple endocrine neoplasia syndromes revisited. Clinical, morphologic, and molecular features.
    DeLellis RA
    Lab Invest; 1995 May; 72(5):494-505. PubMed ID: 7745945
    [No Abstract]   [Full Text] [Related]  

  • 16. Multiple endocrine neoplasia type 2: clinical aspects.
    Gimm O
    Front Horm Res; 2001; 28():103-30. PubMed ID: 11443849
    [No Abstract]   [Full Text] [Related]  

  • 17. RET mutations in multiple endocrine neoplasia type 2 and Hirschsprung disease.
    Reynolds LF; Eng C
    Curr Opin Pediatr; 1995 Dec; 7(6):702-9. PubMed ID: 8776023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lessons learned from the management of a rare genetic cancer.
    Cote GJ; Gagel RF
    N Engl J Med; 2003 Oct; 349(16):1566-8. PubMed ID: 14561800
    [No Abstract]   [Full Text] [Related]  

  • 19. Rudolf-Virchow-Preis 1995. The role of RET proto-oncogene mutation analysis in the diagnosis of multiple endocrine neoplasia type 2 (MEN 2) gene carriers and in the discrimination of sporadic and familial medullary thyroid carcinomas and pheochromocytomas.
    Komminoth P
    Verh Dtsch Ges Pathol; 1995; 79():L-LV. PubMed ID: 8600671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RET oncogene in MEN2, MEN2B, MTC and other forms of thyroid cancer.
    Lodish MB; Stratakis CA
    Expert Rev Anticancer Ther; 2008 Apr; 8(4):625-32. PubMed ID: 18402529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.